These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12269680)

  • 1. Differential expression of matrix metalloproteinase and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions.
    Chegini N; Zhao Y; Kotseos K; Ma C; Bennett B; Diamond MP; Holmdahl L; Skinner K;
    BJOG; 2002 Sep; 109(9):1041-9. PubMed ID: 12269680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions.
    Chegini N; Kotseos K; Zhao Y; Ma C; McLean F; Diamond MP; Holmdahl L; Burns J;
    Fertil Steril; 2001 Dec; 76(6):1212-9. PubMed ID: 11730753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of TGF-beta1 and TGF-beta3 in serosal tissues of human intraperitoneal organs and peritoneal adhesions.
    Chegini N; Kotseos K; Zhao Y; Bennett B; McLean FW; Diamond MP; Holmdahl L; Burns J
    Hum Reprod; 2001 Jun; 16(6):1291-300. PubMed ID: 11387308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions.
    Chegini N; Kotseos K; Bennett B; Diamond MP; Holmdahl L; Burns J;
    Fertil Steril; 2001 Dec; 76(6):1207-11. PubMed ID: 11730752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of integrin alpha v and beta 3 in serosal tissue of human intraperitoneal organs and adhesion.
    Chegini N; Kotseos K; Ma C; Williams RS; Diamond MP; Holmdahl L; Skinner K;
    Fertil Steril; 2001 Apr; 75(4):791-6. PubMed ID: 11287036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
    Davidson B; Reich R; Berner A; Givant-Horwitz V; Goldberg I; Risberg B; Kristensen GB; Trope CG; Bryne M; Kopolovic J; Nesland JM
    Eur J Cancer; 2001 Nov; 37(16):2040-9. PubMed ID: 11597382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid.
    Koks CA; Groothuis PG; Slaats P; Dunselman GA; de Goeij AF; Evers JL
    Fertil Steril; 2000 Mar; 73(3):604-12. PubMed ID: 10689021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
    Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
    Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1.
    Ma C; Chegini N
    Mol Hum Reprod; 1999 Oct; 5(10):950-4. PubMed ID: 10508223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
    Kranzhöfer A; Baker AH; George SJ; Newby AC
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions.
    Diamond MP; El-Hammady E; Wang R; Saed G
    Fertil Steril; 2004 Jan; 81(1):185-90. PubMed ID: 14711564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
    Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
    Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
    Wang X; Li Y; Chen J; Guo X; Guan H; Li C
    Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of hypoxia on the expression of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase mRNA in human periodontal ligament fibroblasts in vitro].
    Song AM; Hou C; Chen JF; Sun J; Tian T; Li S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Oct; 47(10):599-604. PubMed ID: 23302382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
    Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
    Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.